No products in the cart.
IBANDROCARE 150 MG 2 TAB
46.00 EGP
In stock
| * Ibandrocare (Ibandronic acid) 150 mg 2 Film-Coated Scored Tablets. | ||
| * Composition: Each film-coated scored tablet contains: | ||
| & Ibandronate sodium monohydrate 168.75 mg (Equivalent to Ibandronic acid 150 mg). | ||
| * Indications: | ||
| & Treatment and prevention of postmenopausal osteoporosis: | ||
| & IBANDROCARE is indicated for the treatment and prevention of osteoporosis in postmenopausal women. | ||
| & IBANDROCARE increases bone mineral density (BMD) and reduces the incidence of vertebral fractures. | ||
| * Dosage and mode of administration: | ||
| # Dose: | ||
| & The dose of IBANDROCARE is 150 mg F.C. Scored Tablet taken once monthly on the same date each month. | ||
| # Dosing instructions: | ||
| – To maximize absorption and clinical benefit, IBANDROCARE should be taken at least 60 minutes before the | ||
| & first food or drink (other than water) of the day or before taking any oral medication or supplementation | ||
| & including calcium, antacids, or vitamins. | ||
| – To facilitate delivery of the stomach and thus reduce the potential for esophageal irritation (Ibandrocare tablets | ||
| & should be swallowed whole with a full glass of plain water (6 to 8 oz) while the patient is standing or sitting in | ||
| & an upright position. Patients should not lie down for 60 minutes after taking Ibandrocare. Patients should not eat, | ||
| & drink anything except water, or take other medications for at least 60 minutes after taking Ibandrocare. Plain | ||
| & water is the only drink that should be taken with Ibandrocare. Note that some mineral waters may have a higher | ||
| & concentration of calcium and therefore should not be used. Patients should not chew or suck the tablet because | ||
| & of a potential for oropharyngeal ulceration. The Ibandrocare 150 mg tablet should be taken on the same date | ||
| & each month (i.e., the patient’s Ibandrocare day). | ||
| – The patient must not take two Ibandrocare 150 mg tablets within the same week. | ||
| – If the once-monthly dose is missed, and the patients next scheduled Ibandrocare day is more than 7 days away, | ||
| & the patient should be instructed to take IBANDROCARE 150 mg tablet in the morning following the date that it is | ||
| & remembered. The patient should then return to taking one IBANDROCARE 150 mg tablet every month in the | ||
| & morning of their chosen day, according to their original schedule. | ||
| – If the once-monthly dose is missed, and the patient’s next scheduled IBANDROCARE day is 1 to 7 days away | ||
| & the patient must wait until the subsequent month’s scheduled IBANDROCARE day to take their tablet. The patient | ||
| & should then return to taking one IBANDROCARE 150 mg tablet every month in the morning of their chosen day | ||
| & according to their original schedule. | ||
| # Recommendations for calcium and vitamin D supplementation: | ||
| & Patients should receive supplemental calcium and vitamin D if dietary intake is inadequate. | ||
Q & AThere are no questions yet
Ask a question Your question will be answered by a store representative or other customers. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you for the question! Your question has been received and will be answered soon. Please do not submit the same question again. Error 
An error occurred when saving your question. Please report it to the website administrator. Additional information: Add an answer This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you for the answer! Your answer has been received and will be published soon. Please do not submit the same answer again. Error
An error occurred when saving your answer. Please report it to the website administrator. Additional information: Related products
علاج هشاشة العظام
250.00 EGP
علاج هشاشة العظام
199.00 EGP
علاج هشاشة العظام
105.00 EGP
علاج هشاشة العظام
240.00 EGP
|